| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000249846.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.033258982 |
Resistant |
| ENSG00000249846.2 |
Ponatinib |
Thyroid carcinoma |
0.044076111 |
Sensitive |
| ENSG00000249846.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.00709662 |
Resistant |
| ENSG00000249846.2 |
Ponatinib |
Brain lower grade glioma |
0.011207002 |
Resistant |
